Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 03, 2015 4:41 PM ET


Company Overview of Trillium Therapeutics Inc.

Executive Profile

Luke M. Beshar CPA

Independent Director and Chairman of Audit Committee, Trillium Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships


Mr. Luke M. Beshar, CPA, served as Chief Financial Officer and Executive Vice President of NPS Pharmaceuticals, Inc. since November 20, 2007 and January 1, 2012 respectively. Mr. Beshar has 35 years of general and financial management experience. He served as a Senior Vice President of NPS Pharmaceuticals, Inc. from November 20, 2007 to January 1, 2012. He identified and evaluated strategic and corporate development opportunities, lead investor relations, assist in the ...

Corporate Headquarters

96 Skyway Avenue
Toronto, Ontario M9W 4Y9


Phone: 416-595-0627
Fax: --

Board Members Memberships

Independent Director and Chairman of Audit Committee
Independent Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Disclosure Committee


Michigan State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Total Number of Options$6,667

Total Compensation

Total Annual Cash Compensation$49,333
Total Calculated Compensation$181,590

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Trillium Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at